Hélène Labussière Selected Research

Hélène Labussière Research Topics

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2013
3	Leukemia 12/2021 - 08/2011
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2013 - 10/2007
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 11/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2015 - 10/2012
2	Hematologic Neoplasms (Hematological Malignancy) 04/2015 - 08/2012
1	Infections 01/2021
1	Acute Promyelocytic Leukemia 01/2017
1	Aspergillosis 06/2015
1	Colitis 06/2015
1	Multiple Myeloma 12/2013
1	Anemia 01/2013
1	Hematologic Diseases (Blood Diseases) 01/2013
1	Blast Crisis (Blast Phase) 11/2011
1	Philadelphia Chromosome 11/2011
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 09/2011

2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016 - 08/2011
2	Tyrosine Kinase InhibitorsIBA 10/2013 - 11/2011
2	Imatinib Mesylate (Gleevec)FDA Link 10/2013 - 10/2007
1	CPX-351IBA 12/2021
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	Gemtuzumab (Mylotarg)FDA Link 01/2020
1	IronIBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2015
1	Immunomodulating AgentsIBA 12/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2013
1	ponatinibIBA 10/2013
1	HematinicsIBA 01/2013
1	Erythropoietin FDA Link 01/2013
1	AntibodiesIBA 10/2012
1	treosulfanIBA 08/2012
1	eculizumab FDA Link 09/2011
1	AnthracyclinesIBA 08/2011

5	Drug Therapy (Chemotherapy) 01/2017 - 08/2011
3	Therapeutics 12/2021 - 01/2017
3	Hematopoietic Stem Cell Transplantation 01/2017 - 01/2013
2	Stem Cell Transplantation 01/2023 - 11/2011
2	Transplantation 01/2021 - 11/2011
1	Cell Transplantation 01/2021
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2015
1	Induction Chemotherapy 10/2013
1	Homologous Transplantation 10/2013
1	Consolidation Chemotherapy 01/2013